RNA Inhibitor Is Shown Safe and Effective in Reduc

A small interfering RNA (siRNA) investigational therapy that inhibits a gene involved in lipoprotein metabolism has been shown in a clinical trial led by M

Related Keywords

France ,New York ,United States ,Robert Rosenson ,Ilana Nikravesh ,Arrowhead Pharmaceuticals Inc ,Metabolism For The Mount Sinai Health System ,Drug Administration ,Zodasiran Arrowhead Pharmaceuticals ,European Atherosclerosis Society Congress On ,Icahn School Of Medicine At Mount Sinai ,Mount Sinai Press Office ,Wide Range ,Triglyceride Levels ,Mount Sinai Led Clinical Trial ,Mount Sinai ,European Atherosclerosis Society Congress ,New England Journal ,Arrowhead Pharmaceuticals ,Icahn School ,Mount Sinai Health ,